γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Andrew J. Cowan, Margot J. Pont, Blythe Sather, Cameron J. Turtle, Brian G. Till, Edward N. Libby, David G. Coffey, Sherilyn A. Tuazon, Brent L. Wood, Ted Gooley, Vicky Q Wu, Jenna Voutsinas, Xiaoling Song, Mazyar Shadman, Jordan Gauthier, Aude G. Chapuis, Filippo Milano, David G. Maloney, Stanley R. Riddell, Damian J. Green
Topics & Concepts
Chimeric antigen receptorMedicineMultiple myelomaAntigenInternal medicineOncologyBone marrowImmunotherapyImmunologyPharmacologyCancerCancer researchCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsImmunotherapy and Immune Responses